Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen/Codeine vs Paracetamol/Codeine for Postoperative Laminectomy Pain
NCT02255955Phase 4
Key facts
- Status
- Unknown
- Start
- Oct 2014
- Primary completion
- Dec 2014
- Sponsor
- Dışkapı Yıldırım Beyazıt Training and Research Hospital
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Conditions
- postoperative pain
01
Overview
Phase 4, randomised trial of Naproxen sodium + codeine in postoperative pain (3 arms), sponsored by Dışkapı Yıldırım Beyazıt Training and Research Hospital. Primary endpoint: Tramadol (Contramal) consumption at 24 hours. Status: unknown.
02
Design
3 arms- Study design
- Randomized
Naproxen + Codeine
Oral naproxen sodium 550 mg + codeine 30 mg preoperatively
Paracetamol + Codeine
Oral paracetamol 300 mg + codeine 30 mg preoperatively
Placebo
Oral placebo preoperatively
03
Who it enrols
ASA 1 or 2 patients scheduled for elective lumbar disc surgery. Excludes allergies, peptic ulcer, hepatic/renal dysfunction, emergency surgery.
04
Endpoints
Primary
Tramadol (Contramal) consumption
Secondary
Related side effects
Pain intensity measured by VAS
Beyond the preview
Go deeper on NCT02255955.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02255955.